Literature DB >> 23414536

Evaluation of the adult patient with atopic dermatitis.

M S de Bruin Weller1, H Rockmann, A C Knulst, C A F M Bruijnzeel-Koomen.   

Abstract

Atopic dermatitis (AD) is a chronic inflammatory skin disease with a large impact on quality of life of the patients and their families. In most cases, the diagnosis of AD can easily be made based on (family) history and clinical examination. If necessary, a practical set of diagnostic criteria such as the UK diagnostic criteria can be used. During the diagnostic phase, it is important to pay attention to atopic comorbidity, such as allergic airway disease (allergic asthma and/or rhinitis), allergic eye disease (atopic (kerato) conjunctivitis) and immediate-type food allergy. This will not have direct consequences for the treatment of AD, but may be important for the overall well-being of the patient. Psychological factors, such as family circumstances, work/school performance and lifestyle factors should also be explored. Severity scoring using properly validated scoring lists may not be necessary for the diagnosis, however, is recommended for monitoring therapy. Simple scoring systems, such as TIS and IGA are easy to perform in daily practice. Several flare factors in AD, such as exposure to irritants or UV light, can be identified by history and clinical examination: in individual cases, additional diagnostic tests may sometimes be useful to confirm clinical suspicion. There is only limited evidence that allergen exposure to aeroallergens and/or food allergens influences AD severity. Therefore, routine allergen testing is not necessary for diagnosis and treatment of AD. The decision to perform allergen tests mainly depends on atopic comorbidity.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23414536     DOI: 10.1111/cea.12030

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  6 in total

Review 1.  Diet and dermatitis: food triggers.

Authors:  Rajani Katta; Megan Schlichte
Journal:  J Clin Aesthet Dermatol       Date:  2014-03

2.  Danggui buxue tang inhibits 2,4-dinitrochlorobenzene: induced atopic dermatitis in mice.

Authors:  Li-Wen Fang; Chao-Chun Cheng; Tzann-Shun Hwang; Wen-Chung Huang; Chian-Jiun Liou; Wen-Chyuan Chen; Shu-Ju Wu
Journal:  Evid Based Complement Alternat Med       Date:  2015-03-10       Impact factor: 2.629

3.  Osteoporosis in adult patients with atopic dermatitis: A nationwide population-based study.

Authors:  Ching-Ying Wu; Ying-Yi Lu; Chun-Ching Lu; Yu-Feng Su; Tai-Hsin Tsai; Chieh-Hsin Wu
Journal:  PLoS One       Date:  2017-02-16       Impact factor: 3.240

4.  Assessment of serum concentrations of matrix metalloproteinase 1, matrix metalloproteinase 2 and tissue inhibitors of metalloproteinases 1 in atopic dermatitis in correlation with disease severity and epidermal barrier parameters.

Authors:  Magdalena Basałygo; Joanna Śliwiñska; Magdalena Żbikowska-Gotz; Kinga Lis; Ewa Socha; Zbigniew Bartuzi; Barbara Zegarska
Journal:  Postepy Dermatol Alergol       Date:  2021-11-05       Impact factor: 1.837

5.  Chitosan Coated Textiles May Improve Atopic Dermatitis Severity by Modulating Skin Staphylococcal Profile: A Randomized Controlled Trial.

Authors:  Cristina Lopes; Jose Soares; Freni Tavaria; Ana Duarte; Osvaldo Correia; Oksana Sokhatska; Milton Severo; Diana Silva; Manuela Pintado; Luis Delgado; Andre Moreira
Journal:  PLoS One       Date:  2015-11-30       Impact factor: 3.240

6.  Allergic phenotypes in adult patients with atopic dermatitis, determined with the ISAC test (ImmunoCAP ISAC).

Authors:  Milena Wojciechowska; Magdalena Żbikowska-Gotz; Luiza Marek-Józefowicz; Michał Przybyszewski; Jacek Gocki; Zbigniew Bartuzi
Journal:  Postepy Dermatol Alergol       Date:  2018-08-21       Impact factor: 1.837

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.